Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123212595 | 12321259 | 5 | F | 201601 | 20160726 | 20160502 | 20160729 | EXP | GB-ROCHE-1748037 | ROCHE | 80.17 | YR | F | Y | 0.00000 | 20160729 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123212595 | 12321259 | 1 | PS | Trastuzumab | TRASTUZUMAB | 1 | Subcutaneous | Y | 103792 | 600 | MG | SOLUTION FOR INJECTION | Q3W | ||||||
| 123212595 | 12321259 | 2 | SS | LETROZOLE. | LETROZOLE | 1 | Oral | 0 | 2.5 | MG | QD | ||||||||
| 123212595 | 12321259 | 3 | C | WARFARIN | WARFARIN | 1 | Oral | 0 | 1 | MG | TABLET | ||||||||
| 123212595 | 12321259 | 4 | C | ATENOLOL. | ATENOLOL | 1 | Rectal | 0 | 100 | MG | TABLET | ||||||||
| 123212595 | 12321259 | 5 | C | BENDROFLUMETHIAZID | 2 | Oral | 0 | 2.5 | MG | TABLET | |||||||||
| 123212595 | 12321259 | 6 | C | RAMIPRIL. | RAMIPRIL | 1 | Oral | 0 | 5 | MG | TABLET | ||||||||
| 123212595 | 12321259 | 7 | C | DRY DRESSINGS | 2 | Topical | 0 | ||||||||||||
| 123212595 | 12321259 | 8 | C | FLUCLOXACILLIN | FLUCLOXACILLIN | 1 | Oral | 0 | 500 | MG | TABLET | BID | |||||||
| 123212595 | 12321259 | 9 | C | FLUCLOXACILLIN | FLUCLOXACILLIN | 1 | Oral | 0 | 500 | MG | TABLET | /wk | |||||||
| 123212595 | 12321259 | 10 | C | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 0 | 3.3 | MG | INFUSION | ||||||||
| 123212595 | 12321259 | 11 | C | FRUSEMIDE | FUROSEMIDE | 1 | Oral | 0 | 40 | MG | TABLET | BID | |||||||
| 123212595 | 12321259 | 12 | C | NORMAL SALINE | SODIUM CHLORIDE | 1 | Other | PRN | 0 | 1000 | MG | Q8H | |||||||
| 123212595 | 12321259 | 13 | C | CO-DYDRAMOL | ACETAMINOPHENDIHYDROCODEINE | 1 | Oral | 10/500 MG | 0 | TABLET | QID | ||||||||
| 123212595 | 12321259 | 14 | C | TINZAPARIN | TINZAPARIN | 1 | Subcutaneous | DOSE: 3500 UNITS | 0 | ||||||||||
| 123212595 | 12321259 | 15 | C | ORAMORPH | MORPHINE SULFATE | 1 | 0 | ||||||||||||
| 123212595 | 12321259 | 16 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | 0 | ||||||||||||
| 123212595 | 12321259 | 17 | C | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Subcutaneous | 0 | 10 | MG | |||||||||
| 123212595 | 12321259 | 18 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | 0 | 500 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123212595 | 12321259 | 1 | Breast cancer metastatic |
| 123212595 | 12321259 | 2 | Breast cancer metastatic |
| 123212595 | 12321259 | 8 | Cellulitis |
| 123212595 | 12321259 | 11 | Prophylaxis |
| 123212595 | 12321259 | 12 | Prophylaxis |
| 123212595 | 12321259 | 13 | Prophylaxis |
| 123212595 | 12321259 | 18 | Analgesic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123212595 | 12321259 | OT |
| 123212595 | 12321259 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123212595 | 12321259 | Acidosis | |
| 123212595 | 12321259 | Agitation | |
| 123212595 | 12321259 | Anaemia | |
| 123212595 | 12321259 | Blood creatinine increased | |
| 123212595 | 12321259 | Cellulitis | |
| 123212595 | 12321259 | Confusional state | |
| 123212595 | 12321259 | Constipation | |
| 123212595 | 12321259 | Cough | |
| 123212595 | 12321259 | Diverticulum | |
| 123212595 | 12321259 | Hyperglycaemia | |
| 123212595 | 12321259 | Hypoglycaemia | |
| 123212595 | 12321259 | Hypotension | |
| 123212595 | 12321259 | International normalised ratio increased | |
| 123212595 | 12321259 | Melaena | |
| 123212595 | 12321259 | Oropharyngeal pain | |
| 123212595 | 12321259 | Pain | |
| 123212595 | 12321259 | Rectal haemorrhage | |
| 123212595 | 12321259 | Sepsis | |
| 123212595 | 12321259 | Skin disorder | |
| 123212595 | 12321259 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123212595 | 12321259 | 1 | 20151223 | 20160316 | 0 | |
| 123212595 | 12321259 | 2 | 20151103 | 0 | ||
| 123212595 | 12321259 | 3 | 20160217 | 0 | ||
| 123212595 | 12321259 | 8 | 20160106 | 0 | ||
| 123212595 | 12321259 | 9 | 20160205 | 20160211 | 0 | |
| 123212595 | 12321259 | 10 | 20160203 | 0 | ||
| 123212595 | 12321259 | 11 | 20160208 | 20160212 | 0 | |
| 123212595 | 12321259 | 12 | 20160130 | 20160130 | 0 | |
| 123212595 | 12321259 | 13 | 20160130 | 20160204 | 0 | |
| 123212595 | 12321259 | 14 | 20160302 | 20160314 | 0 | |
| 123212595 | 12321259 | 17 | 20160323 | 0 | ||
| 123212595 | 12321259 | 18 | 20160130 | 20160308 | 0 |